Is anyone following this stock ?
Long time since last post. This Sydney based company has just made their first ever sales of their first ever product, the Trophon EPR. A unique disinfection product for probes used in hospitals/clinics. They have at least 3 more products in the pipeline which are at advanced development stages.
I've been following this company for around 5 months and despite that they are a very small cap (now transitioned from research to commercialization) and don't have a great deal of cash, they on the other hand don't have competition and have a global market opening up with a European distribution network already established with an office in Hamburg.
A break above 0.92 could move the stock to 1.075 in six months according to au.stoxline website.
Don't you ever have an opinion of your own? The only posts you make are what stoxline (Stock Doctor) says.
Pray tell what is you association with stoxline/stock doctor???
Addition to the S&P/ASX 300 on 20 March 2015
Was the last buy on my system based portfolio and already lost nearly 20pc
But in the system I trust